Sigrid Therapeutics
Oral porous silica to treat obesity
This article was originally published in Start Up
Executive Summary
Sigrid Therapeutics was spun out from Stockholm-based Nanologica AB to develop treatments for obesity. The start-up’s lead project is an oral formulation of porous silica designed to reduce the absorption of fat from food and help people with a BMI of more than 30 to lose weight.
You may also be interested in...
Biopharma In Sweden: A Comfortable Climate For Start-Ups
Sweden’s biopharmaceutical and life sciences industry now makes up a key part of the country's economy, and the climate is ripe for biotech start-ups.
Biopharma In Sweden: A Comfortable Climate For Start-Ups
Sweden’s biopharmaceutical and life sciences industry now makes up a key part of the country's economy, and the climate is ripe for biotech start-ups. Profiles of Northern Light Pharmaceuticals AB, Sigrid Therapeutics, and Swecure AB.
Gadeta BV: Using T-Cells To Target Metabolic Dysregulation In Cancer
Emerging Company Profile: Gadeta, a Dutch spin-out from University Medical Centre Utrecht, launched earlier this year to develop modified T-cell-based therapies that target metabolic dysregulation in solid and hematological malignancies.